1. Home
  2. VALN vs GBFH Comparison

VALN vs GBFH Comparison

Compare VALN & GBFH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • VALN
  • GBFH
  • Stock Information
  • Founded
  • VALN 2012
  • GBFH 2007
  • Country
  • VALN France
  • GBFH United States
  • Employees
  • VALN N/A
  • GBFH N/A
  • Industry
  • VALN Biotechnology: Biological Products (No Diagnostic Substances)
  • GBFH
  • Sector
  • VALN Health Care
  • GBFH
  • Exchange
  • VALN Nasdaq
  • GBFH NYSE
  • Market Cap
  • VALN 542.5M
  • GBFH 499.0M
  • IPO Year
  • VALN 2021
  • GBFH N/A
  • Fundamental
  • Price
  • VALN $6.00
  • GBFH $37.42
  • Analyst Decision
  • VALN Strong Buy
  • GBFH
  • Analyst Count
  • VALN 3
  • GBFH 0
  • Target Price
  • VALN $15.33
  • GBFH N/A
  • AVG Volume (30 Days)
  • VALN 14.6K
  • GBFH 188.7K
  • Earning Date
  • VALN 08-12-2025
  • GBFH 04-30-2025
  • Dividend Yield
  • VALN N/A
  • GBFH N/A
  • EPS Growth
  • VALN N/A
  • GBFH 53.58
  • EPS
  • VALN N/A
  • GBFH 1.40
  • Revenue
  • VALN $201,099,222.00
  • GBFH $63,591,000.00
  • Revenue This Year
  • VALN $18.74
  • GBFH N/A
  • Revenue Next Year
  • VALN $29.26
  • GBFH $18.88
  • P/E Ratio
  • VALN N/A
  • GBFH $27.28
  • Revenue Growth
  • VALN 21.64
  • GBFH 36.87
  • 52 Week Low
  • VALN $3.62
  • GBFH $16.75
  • 52 Week High
  • VALN $8.66
  • GBFH $46.00
  • Technical
  • Relative Strength Index (RSI)
  • VALN 52.41
  • GBFH N/A
  • Support Level
  • VALN $5.57
  • GBFH N/A
  • Resistance Level
  • VALN $6.19
  • GBFH N/A
  • Average True Range (ATR)
  • VALN 0.29
  • GBFH 0.00
  • MACD
  • VALN 0.05
  • GBFH 0.00
  • Stochastic Oscillator
  • VALN 65.60
  • GBFH 0.00

About VALN Valneva SE

Valneva SE is a vaccine company focused on developing life-saving vaccines. Its portfolio includes three vaccines for travelers. The segments of the group are Commercialized vaccines which relate to marketed vaccines, the group's vaccines IXIARO/JESPECT, DUKORAL, IXCHIQ; Covid includes development, manufacturing, & distribution related to the COVID-19 vaccine, Vaccine candidates which relate to research and development programs to generate new approvable products to generate future cash flows from product sales through partnering with pharmaceutical companies; & Technologies and services which relate to services and inventions at a commercialization stage. The company generates majority of its revenue from product sales.

About GBFH GBANK FINL HLDGS INC

GBank Financial Holdings Inc, through its subsidiary, provides banking services to commercial and consumer customers. The bank accepts deposits from deposit listing services and lends in the local market and national market.

Share on Social Networks: